Cargando…

Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation

BACKGROUND: Acute cellular rejection (ACR) is a major complication after heart transplantation. Endomyocardial biopsy (EMB) remains the gold standard for its diagnosis, but it has concerning complications. We evaluated the usefulness of speckle tracking echocardiography (STE) and biomarkers for dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Cecilia Beatriz Bittencourt Viana, Hajjar, Ludhmila A., Bacal, Fernando, Lofrano-Alves, Marco S., Lima, Márcio S. M., Abduch, Maria C., Viera, Marcelo L. C., Chiang, Hsu P., Salviano, Juliana B. C., da Silva Costa, Isabela Bispo Santos, Fukushima, Julia Tizue, Sbano, Joao C. N., Mathias, Wilson, Tsutsui, Jeane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797113/
https://www.ncbi.nlm.nih.gov/pubmed/33422079
http://dx.doi.org/10.1186/s12947-020-00235-w
_version_ 1783634804481196032
author Cruz, Cecilia Beatriz Bittencourt Viana
Hajjar, Ludhmila A.
Bacal, Fernando
Lofrano-Alves, Marco S.
Lima, Márcio S. M.
Abduch, Maria C.
Viera, Marcelo L. C.
Chiang, Hsu P.
Salviano, Juliana B. C.
da Silva Costa, Isabela Bispo Santos
Fukushima, Julia Tizue
Sbano, Joao C. N.
Mathias, Wilson
Tsutsui, Jeane M.
author_facet Cruz, Cecilia Beatriz Bittencourt Viana
Hajjar, Ludhmila A.
Bacal, Fernando
Lofrano-Alves, Marco S.
Lima, Márcio S. M.
Abduch, Maria C.
Viera, Marcelo L. C.
Chiang, Hsu P.
Salviano, Juliana B. C.
da Silva Costa, Isabela Bispo Santos
Fukushima, Julia Tizue
Sbano, Joao C. N.
Mathias, Wilson
Tsutsui, Jeane M.
author_sort Cruz, Cecilia Beatriz Bittencourt Viana
collection PubMed
description BACKGROUND: Acute cellular rejection (ACR) is a major complication after heart transplantation. Endomyocardial biopsy (EMB) remains the gold standard for its diagnosis, but it has concerning complications. We evaluated the usefulness of speckle tracking echocardiography (STE) and biomarkers for detecting ACR after heart transplantation. METHODS: We prospectively studied 60 transplant patients with normal left and right ventricular systolic function who underwent EMB for surveillance 6 months after transplantation. Sixty age- and sex-matched healthy individuals constituted the control group. Conventional echocardiographic parameters, left ventricular global longitudinal, radial and circumferential strain (LV-GLS, LV-GRS and LV-GCS, respectively), left ventricular systolic twist (LV-twist) and right ventricular free wall longitudinal strain (RV-FWLS) were analyzed just before the procedure. We also measured biomarkers at the same moment. RESULTS: Among the 60 studied patients, 17 (28%) had severe ACR (grade ≥ 2R), and 43 (72%) had no significant ACR (grade 0 – 1R). The absolute values of LV-GLS, LV-twist and RV-FWLS were lower in transplant patients with ACR degree ≥ 2 R than in those without ACR (12.5% ± 2.9% vs 14.8% ± 2.3%, p=0.002; 13.9° ± 4.8° vs 17.1° ± 3.2°, p=0.048; 16.6% ± 2.9% vs 21.4%± 3.2%, p < 0.001; respectively), while no differences were observed between the LV-GRS or LV-GCS. All of these parameters were lower in the transplant group without ACR than in the nontransplant control group, except for the LV-twist. Cardiac troponin I levels were significantly higher in patients with significant ACR than in patients without significant ACR [0.19 ng/mL (0.09–1.31) vs 0.05 ng/mL (0.01–0.18), p=0.007]. The combination of troponin with LV-GLS, RV-FWLS and LV-Twist had an area under curve for the detection of ACR of 0.80 (0.68–0.92), 0.89 (0.81–0.93) and 0.79 (0.66–0.92), respectively. CONCLUSION: Heart transplant patients have altered left ventricular dynamics compared with control individuals. The combination of troponin with strain parameters had higher accuracy for the detection of ACR than the isolated variables and this association might select patients with a higher risk for ACR who will benefit from an EMB procedure in the first year after heart transplantation.
format Online
Article
Text
id pubmed-7797113
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77971132021-01-11 Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation Cruz, Cecilia Beatriz Bittencourt Viana Hajjar, Ludhmila A. Bacal, Fernando Lofrano-Alves, Marco S. Lima, Márcio S. M. Abduch, Maria C. Viera, Marcelo L. C. Chiang, Hsu P. Salviano, Juliana B. C. da Silva Costa, Isabela Bispo Santos Fukushima, Julia Tizue Sbano, Joao C. N. Mathias, Wilson Tsutsui, Jeane M. Cardiovasc Ultrasound Research BACKGROUND: Acute cellular rejection (ACR) is a major complication after heart transplantation. Endomyocardial biopsy (EMB) remains the gold standard for its diagnosis, but it has concerning complications. We evaluated the usefulness of speckle tracking echocardiography (STE) and biomarkers for detecting ACR after heart transplantation. METHODS: We prospectively studied 60 transplant patients with normal left and right ventricular systolic function who underwent EMB for surveillance 6 months after transplantation. Sixty age- and sex-matched healthy individuals constituted the control group. Conventional echocardiographic parameters, left ventricular global longitudinal, radial and circumferential strain (LV-GLS, LV-GRS and LV-GCS, respectively), left ventricular systolic twist (LV-twist) and right ventricular free wall longitudinal strain (RV-FWLS) were analyzed just before the procedure. We also measured biomarkers at the same moment. RESULTS: Among the 60 studied patients, 17 (28%) had severe ACR (grade ≥ 2R), and 43 (72%) had no significant ACR (grade 0 – 1R). The absolute values of LV-GLS, LV-twist and RV-FWLS were lower in transplant patients with ACR degree ≥ 2 R than in those without ACR (12.5% ± 2.9% vs 14.8% ± 2.3%, p=0.002; 13.9° ± 4.8° vs 17.1° ± 3.2°, p=0.048; 16.6% ± 2.9% vs 21.4%± 3.2%, p < 0.001; respectively), while no differences were observed between the LV-GRS or LV-GCS. All of these parameters were lower in the transplant group without ACR than in the nontransplant control group, except for the LV-twist. Cardiac troponin I levels were significantly higher in patients with significant ACR than in patients without significant ACR [0.19 ng/mL (0.09–1.31) vs 0.05 ng/mL (0.01–0.18), p=0.007]. The combination of troponin with LV-GLS, RV-FWLS and LV-Twist had an area under curve for the detection of ACR of 0.80 (0.68–0.92), 0.89 (0.81–0.93) and 0.79 (0.66–0.92), respectively. CONCLUSION: Heart transplant patients have altered left ventricular dynamics compared with control individuals. The combination of troponin with strain parameters had higher accuracy for the detection of ACR than the isolated variables and this association might select patients with a higher risk for ACR who will benefit from an EMB procedure in the first year after heart transplantation. BioMed Central 2021-01-09 /pmc/articles/PMC7797113/ /pubmed/33422079 http://dx.doi.org/10.1186/s12947-020-00235-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cruz, Cecilia Beatriz Bittencourt Viana
Hajjar, Ludhmila A.
Bacal, Fernando
Lofrano-Alves, Marco S.
Lima, Márcio S. M.
Abduch, Maria C.
Viera, Marcelo L. C.
Chiang, Hsu P.
Salviano, Juliana B. C.
da Silva Costa, Isabela Bispo Santos
Fukushima, Julia Tizue
Sbano, Joao C. N.
Mathias, Wilson
Tsutsui, Jeane M.
Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
title Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
title_full Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
title_fullStr Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
title_full_unstemmed Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
title_short Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
title_sort usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797113/
https://www.ncbi.nlm.nih.gov/pubmed/33422079
http://dx.doi.org/10.1186/s12947-020-00235-w
work_keys_str_mv AT cruzceciliabeatrizbittencourtviana usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT hajjarludhmilaa usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT bacalfernando usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT lofranoalvesmarcos usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT limamarciosm usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT abduchmariac usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT vieramarcelolc usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT chianghsup usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT salvianojulianabc usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT dasilvacostaisabelabisposantos usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT fukushimajuliatizue usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT sbanojoaocn usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT mathiaswilson usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation
AT tsutsuijeanem usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation